SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Sean McCarthy will join a roundtable discussion of "How to Transform your Technology into a Sustainable Marketable Product" at the San Jose BioCenter.
News | 03. 22. 2007
